Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Sports
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Yield
How to Buy Corporate Bonds
How to Buy Treasury Bonds
How to Invest in Real Estate Online
Money
Compare Online Brokers
Stock Brokers
Forex Brokers
Futures Brokers
Crypto Brokers
Options Brokers
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
All Broker Reviews
Insurance
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Motorcycle
Renters
Workers Comp
Top Stocks
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Alternative Investing
Invest in Art
Invest in Watches
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Mortgages
Refinance
Purchase
Find a Mortgage Broker
Consumer
Moving
Living
Alts
Alternative Investment Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
How to Invest in Jewelry
Best Real Estate Crowdfunding Platforms
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Get Started
Is Bitcoin a Good Investment?
Is Ethereum a Good Investment?
What is Blockchain
Best Altcoins
How to Buy Cryptocurrency?
DeFi
Crypto and DeFi 101
What is DeFi?
Decentralized Exchanges
Best DeFi Yield Farms
Digital Securities
NFTs
NFT Release Calendar
What is a Non-Fungible Token (NFT)?
How to Buy Non-Fungible Tokens (NFTs)
CryptoPunks Watchlist
Are NFTs a Scam or a Digital Bubble?
Best In Crypto
Best Crypto Apps
Best Crypto Portfolio Trackers
Best Crypto Day Trading Strategies
Best Crypto IRA
Best Cryptocurrency Scanners
Best Business Crypto Accounts
Best Crypto Screeners
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Yield
How to Buy Corporate Bonds
How to Buy Treasury Bonds
How to Invest in Real Estate Online
Money
Compare Online Brokers
Stock Brokers
Forex Brokers
Futures Brokers
Crypto Brokers
Options Brokers
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
All Broker Reviews
Insurance
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Motorcycle
Renters
Workers Comp
Top Stocks
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Alternative Investing
Invest in Art
Invest in Watches
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Mortgages
Refinance
Purchase
Find a Mortgage Broker
Consumer
Moving
Living
Alts
Alternative Investment Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
How to Invest in Jewelry
Best Real Estate Crowdfunding Platforms
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Get Started
Is Bitcoin a Good Investment?
Is Ethereum a Good Investment?
What is Blockchain
Best Altcoins
How to Buy Cryptocurrency?
DeFi
Crypto and DeFi 101
What is DeFi?
Decentralized Exchanges
Best DeFi Yield Farms
Digital Securities
NFTs
NFT Release Calendar
What is a Non-Fungible Token (NFT)?
How to Buy Non-Fungible Tokens (NFTs)
CryptoPunks Watchlist
Are NFTs a Scam or a Digital Bubble?
Best In Crypto
Best Crypto Apps
Best Crypto Portfolio Trackers
Best Crypto Day Trading Strategies
Best Crypto IRA
Best Cryptocurrency Scanners
Best Business Crypto Accounts
Best Crypto Screeners
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
iRadimed
(NASDAQ:IRMD)
Intraday
$44.39
0.12
[0.27%]
After-Hours
$44.39
0
[0.00%]
GET A REPORT ON
IRMD
SENT RIGHT TO YOUR INBOX
EMAIL*
Submit
Cancel
Get Report
Watch
Perks
Buy
Compare Brokers
$44.39
0.12
[0.27%]
At close: Mar 18
$44.39
0
[0.00%]
After Hours: 4:00PM EDT
GET A REPORT ON
IRMD
SENT RIGHT TO YOUR INBOX
EMAIL*
Submit
Cancel
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for iRadimed Stock (NASDAQ:IRMD)
iRadimed Stock (NASDAQ: IRMD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, February 08, 2024
IRadimed Forecasts FY24 Revenue of $72M-$74M, With Adjusted EPS Of $1.52-$1.62 Compared To Consensus Of $71.50M And $1.48, Respectively
Benzinga Newsdesk
-
Feb 8, 2024, 8:10AM
IRadimed Forecasts Q1 FY24 Revenue of $17M-$17.3M, With Adjusted EPS Of $0.33-$0.35 Compared To Consensus Of $16.50M And $0.32, Respectively
Benzinga Newsdesk
-
Feb 8, 2024, 8:08AM
iRadimed Q4 Adjusted EPS $0.39 Misses $0.40 Estimate, Sales $17.45M Beat $17.33M Estimate
Benzinga Newsdesk
-
Feb 8, 2024, 8:06AM
Earnings Scheduled For February 8, 2024
Benzinga Insights
-
Feb 8, 2024, 4:43AM
Wednesday, February 07, 2024
iRadimed's Earnings Outlook
Benzinga Insights
-
Feb 7, 2024, 1:02PM
Tuesday, January 09, 2024
IRADIMED CORPORATION Reports Unaudited Q4 Revenue $17.5M Vs $17.13M Est.; FY23 Revenue $65.6M Vs $65.07M Est.
Benzinga Newsdesk
-
Jan 9, 2024, 8:38AM
Monday, December 18, 2023
Wednesday Is Your Last Chance To Buy iRadimed Before The Dividend Payout
Benzinga Insights
-
Dec 18, 2023, 9:45AM
Friday, November 03, 2023
IRADIMED shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 adjusted EPS guidance above estimates. Also, the company issued FY23 guidance above estimates.
Benzinga Newsdesk
-
Nov 3, 2023, 12:24PM
IRADIMED Sees FY23 Adjusted EPS Of $1.48-$1.51 Versus Consensus Of $1.26 And Prior Range Of $1.37-$1.40
Benzinga Newsdesk
-
Nov 3, 2023, 8:09AM
IRADIMED Sees FY23 Revenue Of $65.0M-$65.5M Versus Consensus Of $64.77M And Prior Range Of $64.5M-$65.5M
Benzinga Newsdesk
-
Nov 3, 2023, 8:08AM
IRADIMED Sees Q4 FY23 Adjusted EPS Of $0.38-$0.41 Versus Consensus Of $0.33
Benzinga Newsdesk
-
Nov 3, 2023, 8:05AM
IRADIMED Sees Q4 FY23 Revenue Of $16.9M-$17.4M Versus Consensus Of $17.01M
Benzinga Newsdesk
-
Nov 3, 2023, 8:04AM
iRadimed Q3 Adjusted EPS $0.43 Beats $0.36 Estimate, Sales $16.50M Beat $16.17M Estimate
Benzinga Newsdesk
-
Nov 3, 2023, 8:02AM
Earnings Scheduled For November 3, 2023
Benzinga Insights
-
Nov 3, 2023, 7:12AM
Thursday, November 02, 2023
iRadimed's Earnings: A Preview
Benzinga Insights
-
Nov 2, 2023, 1:02PM
Friday, October 13, 2023
Caleres, Cloudflare And 2 Other Stocks Insiders Are Selling
Lisa Levin
-
Oct 13, 2023, 8:26AM
Thursday, August 03, 2023
IRadimed Corporation shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 and FY23 guidance above estimates.
Benzinga Newsdesk
-
Aug 3, 2023, 3:07PM
IRadimed Expects FY23 Revenue Of $64.5M-$65.5M Vs. Prior Guidance Of $62M-$63.5M And Consensus Of $63.09M; It Sees Adjusted EPS Of $1.37-$1.40 Vs. Previous Outlook Of $1.26-$1.35 And Consensus Of $1.30
Benzinga Newsdesk
-
Aug 3, 2023, 8:12AM
IRadimed Expects Q3 FY23 Revenue Of $16.1M-$16.3M Vs. Consensus Of $15.6M; Sees Adjusted EPS OF $0.36-$0.38 Vs. Consensus Of $0.33
Benzinga Newsdesk
-
Aug 3, 2023, 8:08AM
iRadimed Q2 Adjusted EPS $0.36 Beats $0.31 Estimate, Sales $16.13M Beat $15.65M Estimate
Benzinga Newsdesk
-
Aug 3, 2023, 8:02AM
Earnings Scheduled For August 3, 2023
Benzinga Insights
-
Aug 3, 2023, 6:59AM
Thursday, June 08, 2023
Massive Insider Trade At iRadimed
Benzinga Insights
-
Jun 8, 2023, 11:03AM
Tuesday, May 09, 2023
iRadimed President Sold $461K In Company Stock
Benzinga Insights
-
May 9, 2023, 11:03AM
Thursday, May 04, 2023
iRadimed: Q1 Earnings Insights
Benzinga Insights
-
May 4, 2023, 9:30AM
iRadimed Boosts FY23 Revenue Guidance From $61.0M-$63.0M To $62M-$63.5M (Consensus $62.51M) , Adj. EPS From $1.23-$1.34 To $1.26-$1.35 (Consensus $1.31)
Benzinga Newsdesk
-
May 4, 2023, 8:35AM
iRadimed Expects Q2 Revenue Of $15.6M-$15.8M (Consensus $15.1M), Adjusted EPS Of $0.30-$0.32 (Consensus $0.30)
Benzinga Newsdesk
-
May 4, 2023, 8:33AM
iRadimed Q1 Adj EPS $0.30 Beats $0.28 Estimate, Sales $15.47M Beat $14.77M Estimate
Benzinga Newsdesk
-
May 4, 2023, 8:31AM
Earnings Scheduled For May 4, 2023
Benzinga Insights
-
May 4, 2023, 6:34AM
Wednesday, May 03, 2023
iRadimed's Earnings: A Preview
Benzinga Insights
-
May 3, 2023, 1:00PM
Monday, February 27, 2023
Iradimed Notifies Potential Issue With Certain Syringe Adapter Sets During Use
Vandana Singh
-
Feb 27, 2023, 6:27AM
Friday, February 24, 2023
IRadimed Issues Urgent Medical Device Correction To Notify Affected Customers Of Potential issue With Some 1057 Syringe Adapter Sets Related To Syringe Venting Function
Michael Horton
-
Feb 24, 2023, 4:20PM
Thursday, February 02, 2023
IRADIMED Expects FY23 Adjusted EPS Of $1.23-$1.34 Compared To Consensus Of $1.30, Expects Sales Of $61M-$63M Vs. Consensus Of $62.84M
Benzinga Newsdesk
-
Feb 2, 2023, 8:15AM
IRADIMED's Board Has Approved Special Cash Dividend Of $1.05/Share Payable On February 21, 2023, For Record Date Of February 13, 2023
Benzinga Newsdesk
-
Feb 2, 2023, 8:10AM
iRadimed Q4 Adjusted EPS $0.32 Beats $0.30 Estimate, Sales $14.86M Miss $14.87M Estimate
Benzinga Newsdesk
-
Feb 2, 2023, 8:03AM
Wednesday, February 01, 2023
iRadimed's Earnings Outlook
Benzinga Insights
-
Feb 1, 2023, 4:01PM
Wednesday, January 18, 2023
IRADIMED CORPORATION Sees Prelim. Q4 Revenue $14.9M vs $14.63M Est.
Benzinga Newsdesk
-
Jan 18, 2023, 8:01AM
Tuesday, November 22, 2022
iRadimed's Return On Capital Employed Insights
Benzinga Insights
-
Nov 22, 2022, 9:50AM
Thursday, November 03, 2022
IRADIMED CORPORATION Reiterated Q4 Revenue Guidance $14.1M-$14.8M; Q4 Non-GAAP EPS $0.25-$0.30; FY22 Revenue Guidance $52.5M-$53.2M; FY22 Non-GAAP EPS $1.03-$1.08
Benzinga Newsdesk
-
Nov 3, 2022, 8:54AM
Recap: iRadimed Q3 Earnings
Benzinga Insights
-
Nov 3, 2022, 7:46AM
iRadimed Q3 Adj. EPS $0.29 Beats $0.24 Estimate, Sales $13.40M Beat $13.19M Estimate
Benzinga Newsdesk
-
Nov 3, 2022, 7:09AM
Earnings Scheduled For November 3, 2022
Benzinga Insights
-
Nov 3, 2022, 5:42AM
Wednesday, November 02, 2022
A Preview Of iRadimed's Earnings
Benzinga Insights
-
Nov 2, 2022, 3:05PM
Wednesday, October 12, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 12, 2022, 1:32PM
Tuesday, October 11, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 11, 2022, 12:47PM
Monday, October 10, 2022
Iradimed Withdraws FDA Application For Updated MR IV Pump System
Vandana Singh
-
Oct 10, 2022, 11:24AM
IRADIMED Sees Prelim. Q3 Sales $13.4M vs $13.19M Est.
Bill Haddad
-
Oct 10, 2022, 8:02AM
IRADIMED CORPORATION Withdraws 510(k) With Plans To Resubmit After Further Discussions With FDA
Bill Haddad
-
Oct 10, 2022, 8:00AM
Wednesday, October 05, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 5, 2022, 12:43PM
Thursday, August 25, 2022
Tesla, Autodesk And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Lisa Levin
-
Aug 25, 2022, 6:07AM
Friday, July 29, 2022
iRadimed Q3 EPS $0.45 Up From $0.23 YoY
Benzinga Newsdesk
-
Jul 29, 2022, 11:02AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch